These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16312524)

  • 1. Bioavailability and pharmacokinetics of enoxacin.
    Nakamura S; Kurobe N; Sekine Y
    J Chemother; 1989 Jul; 1(4 Suppl):543-4. PubMed ID: 16312524
    [No Abstract]   [Full Text] [Related]  

  • 2. Quinolone pharmacokinetics and metabolism.
    Lode H; Höffken G; Boeckk M; Deppermann N; Borner K; Koeppe P
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():41-9. PubMed ID: 2124212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of fleroxacin determined by biological method.
    Verbist L; Van Hecken A; De Schepper P
    J Chemother; 1989 Jul; 1(4 Suppl):572-3. PubMed ID: 16312537
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of enoxacin and its oxometabolite after multiple oral dosing and penetration into prostatic tissue.
    Hamel B; Mottet N; Audran M; Costa P; Bressolle F
    J Antimicrob Chemother; 2000 Dec; 46(6):993-6. PubMed ID: 11102420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of enoxacin in subjects with renal or hepatic impairment.
    Novelli A; Reali EF; Amato M; Dami A; Fallani S; Periti P
    J Chemother; 1989 Jul; 1(4 Suppl):546-8. PubMed ID: 16312526
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics and bioavailability of intravenous-to-oral enoxacin in elderly patients with complicated urinary tract infections.
    Marchbanks CR; Mikolich DJ; Mayer KH; Zinner SH; Dudley MN
    Antimicrob Agents Chemother; 1990 Oct; 34(10):1966-72. PubMed ID: 2291662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Enoxacin--comparative pharmacokinetics and tissue penetration].
    Sörgel F; Naber KG; Metz R; Morgenroth A
    Infection; 1989; 17 Suppl 1():S14-8. PubMed ID: 2680989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of enrofloxacin in Korean catfish (Silurus asotus).
    Kim MS; Lim JH; Park BK; Hwang YH; Yun HI
    J Vet Pharmacol Ther; 2006 Oct; 29(5):397-402. PubMed ID: 16958784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative bioequivalence and pharmacokinetics of ciprofloxacin in healthy male subjects.
    Khan MK; Khan MF
    Pak J Pharm Sci; 2009 Jan; 22(1):1-7. PubMed ID: 19168412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative bioavailability of two oral formulations of ciprofloxacin.
    Trejo D; Toledo A; Carrasco-Portugal Mdel C; Aguilar-Cota ME; Herrera JE; Flores-Murrieta FJ
    Proc West Pharmacol Soc; 2003; 46():134-5. PubMed ID: 14699910
    [No Abstract]   [Full Text] [Related]  

  • 11. Preparation and evaluation of sustained ophthalmic gel of enoxacin.
    Liu Z; Pan W; Nie S; Zhang L; Yang X; Li J
    Drug Dev Ind Pharm; 2005 Dec; 31(10):969-75. PubMed ID: 16316852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of Ro 23-6240 (AM 833), a new trifluorinated quinolone.
    Weidekamm E; Stöckel K; Dell D
    Chemioterapia; 1987 Jun; 6(2 Suppl):307-8. PubMed ID: 3151346
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of difloxacin in pigs and broilers following intravenous, intramuscular, and oral single-dose applications.
    Ding HZ; Yang GX; Huang XH; Chen ZL; Zeng ZL
    J Vet Pharmacol Ther; 2008 Jun; 31(3):200-4. PubMed ID: 18471140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Article IV: clinical application of pharmacokinetics.
    Martinez MN
    J Am Vet Med Assoc; 1998 Nov; 213(10):1418-20. PubMed ID: 9828932
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of renal impairment and haemodialysis on single dose pharmacokinetics of oral enoxacin.
    Nix DE; Schultz RW; Frost RW; Sedman AJ; Thomas DJ; Kinkel AW; Schentag JJ
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():87-95. PubMed ID: 3162906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of fleroxacin in horses.
    Rebuelto M; Otero P; Albarellos G; Ambros L; Kreil V; Waxman S; Montoya L; Hallu R
    J Vet Pharmacol Ther; 2000 Apr; 23(2):103-5. PubMed ID: 10849255
    [No Abstract]   [Full Text] [Related]  

  • 17. Enrofloxacin and marbofloxacin in horses: comparison of pharmacokinetic parameters, use of urinary and metabolite data to estimate first-pass effect and absorbed fraction.
    Peyrou M; Bousquet-Melou A; Laroute V; Vrins A; Doucet MY
    J Vet Pharmacol Ther; 2006 Oct; 29(5):337-44. PubMed ID: 16958777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of absolute bioavailability for drugs using oral and renal clearance following a single oral dose: a critical view.
    Mahmood I
    Biopharm Drug Dispos; 1997 Aug; 18(6):465-73. PubMed ID: 9267680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The absorption and disposition of enoxacin in healthy subjects.
    Somogyi AA; Bochner F
    J Clin Pharmacol; 1988 Aug; 28(8):707-13. PubMed ID: 3216037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation on transdermal delivery of enoxacin via chemical enhancers and physical iontophoresis.
    Fang JY; Lin HH; Chen HI; Tsai YH
    J Control Release; 1998 Aug; 54(3):293-304. PubMed ID: 9766249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.